Clinical Observations and Interactions Between HBV Infection and B-NHL: Comments on High Prevalence of Hepatitis B Virus Infection in Patients with Aggressive B Cell non-Hodgkin's Lymphoma in China

doi:10.15344/2456-4028/2018/133

Graphy

Profile

New User

New to Graphy Publications? Create an account to get started today.

Create Account For:

Registered Users

Have an account? Sign in now.

Article Menu

Journal Menu

How to Cite | Author Information | Publication History

International Journal of Clinical & Medical Microbiology Volume 3 (2018), Article ID 3:IJCMM-133, 1 pages
https://doi.org/10.15344/2456-4028/2018/133

Commentary

Clinical Observations and Interactions Between HBV Infection and B-NHL: Comments on High Prevalence of Hepatitis B Virus Infection in Patients with Aggressive B Cell non-Hodgkin's Lymphoma in China

Qing Zhang

Cancer Institute and Hospital, Tianjin Medical University, 22 Qixiangtai Road, Tianjin, Tianjin, China

Corresponding Author Details: Dr. Qing Zhang, Cancer Institute and Hospital, Tianjin Medical University, 22 Qixiangtai Road, Tianjin, China; E-mail: qzhang1983@tmu.edu.cn

Received: 24 May 2018; Accepted: 09 June 2018; Published: 11 June 2018

Citation: Zhang Q (2018) Clinical Observations and Interactions Between HBV Infection and B-NHL: Comments on High Prevalence of Hepatitis B Virus Infection in Patients with Aggressive B Cell non-Hodgkin's Lymphoma in China, Reported by Wang etc. Int J Clin Med Microbiol 3: 133. doi: https://doi.org/10.15344/2456-4028/2018/133

Copyright: © 2018 Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

Liang X, Bi S, Yang W, Wang L, Cui G, et al. (2009) Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 27: 6550-6557 [CrossRef] [PubMed]
Zhou YH, Wu C, Zhuang H (2009) Vaccination against hepatitis B: the Chinese experience. Chin Med J 122: 98-102 [CrossRef] [Google Scholar] [PubMed]
Coluccio C, Begini P, Marzano A, Pellicelli A, Imperatrice B, et al. (2017) Hepatitis B in patients with hematological disease: an update. World J Hepatol 9: 1043-1053 [CrossRef] [Google Scholar] [PubMed]
Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, et al. (2014) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr 2014: 130-144 [CrossRef] [Google Scholar] [PubMed]
Marcucci F, Mele A (2011) Hepatitis viruses and NHL: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood 117: 1792-1798 [CrossRef] [Google Scholar] [PubMed]
Lim ST, Fei G, Quek R, Lim LC, Lee LH, et al. (2007) The relationship of hepatitis B virus infection and non-Hodgkin’s lymphoma and its impact on clinical characteristics and prognosis. Eur J Haematol 79: 132-137 [CrossRef] [Google Scholar] [PubMed]
Wang C, Xia B, Ning Q, Zhao H, Yang H, et al. (2018) High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin's lymphoma in China. Ann Hematol 97: 453-457 [CrossRef] [Google Scholar] [PubMed]

Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version